English (United States)
 

Clinical trials: clearer rules, better protection for patients

15/04/14
reduce font Size enlarge font Size print content
 
NWI5563HM87RD464.jpg

MEPs vote for more transparency in European Clinical Trials

Members of the European Parliament have by a huge majority voted for the adoption of the new Clinical Trials Regulation. Among other novelties, the new law requires publishing results of all European clinical trials in a publicly-accessible database within one year of the trials end.

Please find the official press release from the 2nd of April 2014 under following link:

http://www.europarl.europa.eu/news/en/news-room/content/20140331IPR41186/html/Clinical-trials-clearer-rules-better-protection-for-patients

Please find more information about requirement of the new law on the AllTrials campaign website:

http://www.alltrials.net/2014/europe-votes-for-clinical-trial-transparency/

 

 

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.